435 related articles for article (PubMed ID: 18276079)
1. Effects of neuron-specific ADAM10 modulation in an in vivo model of acute excitotoxic stress.
Clement AB; Hanstein R; Schröder A; Nagel H; Endres K; Fahrenholz F; Behl C
Neuroscience; 2008 Mar; 152(2):459-68. PubMed ID: 18276079
[TBL] [Abstract][Full Text] [Related]
2. Effect of a dominant-negative form of ADAM10 in a mouse model of Alzheimer's disease.
Schroeder A; Fahrenholz F; Schmitt U
J Alzheimers Dis; 2009; 16(2):309-14. PubMed ID: 19221420
[TBL] [Abstract][Full Text] [Related]
3. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
Corbett GT; Gonzalez FJ; Pahan K
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
[TBL] [Abstract][Full Text] [Related]
4. A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model.
Postina R; Schroeder A; Dewachter I; Bohl J; Schmitt U; Kojro E; Prinzen C; Endres K; Hiemke C; Blessing M; Flamez P; Dequenne A; Godaux E; van Leuven F; Fahrenholz F
J Clin Invest; 2004 May; 113(10):1456-64. PubMed ID: 15146243
[TBL] [Abstract][Full Text] [Related]
5. Differential gene expression in ADAM10 and mutant ADAM10 transgenic mice.
Prinzen C; Trümbach D; Wurst W; Endres K; Postina R; Fahrenholz F
BMC Genomics; 2009 Feb; 10():66. PubMed ID: 19196476
[TBL] [Abstract][Full Text] [Related]
6. Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice.
Dewachter I; Reversé D; Caluwaerts N; Ris L; Kuipéri C; Van den Haute C; Spittaels K; Umans L; Serneels L; Thiry E; Moechars D; Mercken M; Godaux E; Van Leuven F
J Neurosci; 2002 May; 22(9):3445-53. PubMed ID: 11978821
[TBL] [Abstract][Full Text] [Related]
7. η-Secretase processing of APP inhibits neuronal activity in the hippocampus.
Willem M; Tahirovic S; Busche MA; Ovsepian SV; Chafai M; Kootar S; Hornburg D; Evans LD; Moore S; Daria A; Hampel H; Müller V; Giudici C; Nuscher B; Wenninger-Weinzierl A; Kremmer E; Heneka MT; Thal DR; Giedraitis V; Lannfelt L; Müller U; Livesey FJ; Meissner F; Herms J; Konnerth A; Marie H; Haass C
Nature; 2015 Oct; 526(7573):443-7. PubMed ID: 26322584
[TBL] [Abstract][Full Text] [Related]
8. Metalloprotease Adam10 suppresses epilepsy through repression of hippocampal neuroinflammation.
Zhu X; Li X; Zhu M; Xu K; Yang L; Han B; Huang R; Zhang A; Yao H
J Neuroinflammation; 2018 Aug; 15(1):221. PubMed ID: 30075790
[TBL] [Abstract][Full Text] [Related]
9. Determination of the proteolytic cleavage sites of the amyloid precursor-like protein 2 by the proteases ADAM10, BACE1 and γ-secretase.
Hogl S; Kuhn PH; Colombo A; Lichtenthaler SF
PLoS One; 2011; 6(6):e21337. PubMed ID: 21695060
[TBL] [Abstract][Full Text] [Related]
10. Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein.
Harris B; Pereira I; Parkin E
Brain Res; 2009 Nov; 1296():203-15. PubMed ID: 19679113
[TBL] [Abstract][Full Text] [Related]
11. Dysregulated ADAM10-Mediated Processing of APP during a Critical Time Window Leads to Synaptic Deficits in Fragile X Syndrome.
Pasciuto E; Ahmed T; Wahle T; Gardoni F; D'Andrea L; Pacini L; Jacquemont S; Tassone F; Balschun D; Dotti CG; Callaerts-Vegh Z; D'Hooge R; Müller UC; Di Luca M; De Strooper B; Bagni C
Neuron; 2015 Jul; 87(2):382-98. PubMed ID: 26182420
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin.
Tippmann F; Hundt J; Schneider A; Endres K; Fahrenholz F
FASEB J; 2009 Jun; 23(6):1643-54. PubMed ID: 19144697
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of APP, ADAM10 and ADAM17 in the denervated mouse dentate gyrus.
Del Turco D; Schlaudraff J; Bonin M; Deller T
PLoS One; 2014; 9(1):e84962. PubMed ID: 24404197
[TBL] [Abstract][Full Text] [Related]
14. Phenylbutyric acid reduces amyloid plaques and rescues cognitive behavior in AD transgenic mice.
Wiley JC; Pettan-Brewer C; Ladiges WC
Aging Cell; 2011 Jun; 10(3):418-28. PubMed ID: 21272191
[TBL] [Abstract][Full Text] [Related]
15. Transgenic overexpression of corticotropin releasing hormone provides partial protection against neurodegeneration in an in vivo model of acute excitotoxic stress.
Hanstein R; Lu A; Wurst W; Holsboer F; Deussing JM; Clement AB; Behl C
Neuroscience; 2008 Oct; 156(3):712-21. PubMed ID: 18708129
[TBL] [Abstract][Full Text] [Related]
16. Proteolytic cleavage of amyloid precursor protein by ADAM10 mediates proliferation and migration in breast cancer.
Tsang JYS; Lee MA; Chan TH; Li J; Ni YB; Shao Y; Chan SK; Cheungc SY; Lau KF; Tse GMK
EBioMedicine; 2018 Dec; 38():89-99. PubMed ID: 30470613
[TBL] [Abstract][Full Text] [Related]
17. Cryptotanshinione upregulates alpha-secretase by activation PI3K pathway in cortical neurons.
Mei Z; Situ B; Tan X; Zheng S; Zhang F; Yan P; Liu P
Brain Res; 2010 Aug; 1348():165-73. PubMed ID: 20595051
[TBL] [Abstract][Full Text] [Related]
18. Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's disease.
Reinhardt S; Schuck F; Grösgen S; Riemenschneider M; Hartmann T; Postina R; Grimm M; Endres K
FASEB J; 2014 Feb; 28(2):978-97. PubMed ID: 24165480
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of non-amyloidogenic processing of amyloid-β protein precursor by cryptotanshinone involves activation and translocation of ADAM10 and PKC-α.
Durairajan SS; Liu LF; Lu JH; Koo I; Maruyama K; Chung SK; Huang JD; Li M
J Alzheimers Dis; 2011; 25(2):245-62. PubMed ID: 21403388
[TBL] [Abstract][Full Text] [Related]
20. Octyl gallate markedly promotes anti-amyloidogenic processing of APP through estrogen receptor-mediated ADAM10 activation.
Zhang SQ; Sawmiller D; Li S; Rezai-Zadeh K; Hou H; Zhou S; Shytle D; Giunta B; Fernandez F; Mori T; Tan J
PLoS One; 2013; 8(8):e71913. PubMed ID: 23977176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
